Featured
-
-
Comment |
scFv6.C4 DNA vaccine with fragment C of tetanus toxin increases protective immunity against CEA-expressing tumor
- Anjali Geethadevi
- , Kapilesh Jadhav
- & Deepak Parashar
-
Article |
scFv6.C4 DNA vaccine with fragment C of Tetanus toxin increases protective immunity against CEA-expressing tumor
- Bianca Ferrarini Zanetti
- , Camila Pontes Ferreira
- & Sang Won Han
-
Article |
LncRNA FTX sponges miR-215 and inhibits phosphorylation of vimentin for promoting colorectal cancer progression
- Yi Yang
- , Jinpei Zhang
- & Tao Wu
-
Original Article
| Open AccessBalanced secretion of anti-CEA × anti-CD3 diabody chains using the 2A self-cleaving peptide maximizes diabody assembly and tumor-specific cytotoxicity
- K Mølgaard
- , M Compte
- & L Alvarez-Vallina
-
Original Article |
Treatment of colon cancer with oncolytic herpes simplex virus in preclinical models
- H Yang
- , T Peng
- & B Liu
-
Original Article |
Clonal variation in interferon response determines the outcome of oncolytic virotherapy in mouse CT26 colon carcinoma model
- J J Ruotsalainen
- , M U Kaikkonen
- & M J Vähä-Koskela
-
Original Article |
Efficient gene transfer using the human JC virus-like particle that inhibits human colon adenocarcinoma growth in a nude mouse model
- L-S Chen
- , M Wang
- & D Chang
-
Original Article |
TRAIL gene-armed oncolytic poxvirus and oxaliplatin can work synergistically against colorectal cancer
- M F Ziauddin
- , Z S Guo
- & D L Bartlett